Grippferon

Country of origin: Russia
Pharm-Group: Antiviral agents of different groups

Manufacturers: Firn M (Russia)
International name: Grippferon
Dosage forms: nasal drops 10000IU/ml
Composition: Grippferon is a recombinant human interferon alpha-2, obtained by genetic engineering (without the use of human blood) in a polymer base (polyvinylpyrrolidone, polyethylene oxide and Trilon B in water). 1 ml solution in the form of drops

Indications for use: Prevention and treatment of influenza and ARVI in children and adults in the first stages of the disease (1-3 days).

Contraindications: Individual intolerance to interferon drugs, severe forms of allergic diseases.

Side effect: No data.

Interaction: No data available.

Overdose: No data.

Special instructions: The use of intranasal vasoconstrictor drugs in combination with Grippferon is not recommended, as this contributes to additional drying of the nasal mucosa. USE IN PREGNANCY Grippferon is approved for use throughout the entire period of pregnancy in accordance with the age-specific dosage.

Literature:

1. Instructions for the use of "Grippferon" were approved by the Chief State Sanitary Doctor of the Russian Federation on January 4, 2004.
2. Prospectus of the manufacturer.